Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACE | P12821 | 2/20 | 0.62 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.61 |
| ▸ | CTSL | P07711 | 2/20 | 0.57 |
| ▸ | CTSS | P25774 | 1/20 | 0.57 |
| ▸ | CTSK | P43235 | 1/20 | 0.57 |
| ▸ | TACR1 | P25103 | 2/20 | 0.57 |
| ▸ | MAPT | P10636 | 3/20 | 0.56 |
| ▸ | BLM | P54132 | 2/20 | 0.56 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.56 |
| ▸ | LMNA | P02545 | 1/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.56 |
| ▸ | HTR1A | P08908 | 1/20 | 0.56 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.56 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.56 |
| ▸ | TSHR | P16473 | 1/20 | 0.56 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.56 |
| ▸ | HTR2A | P28223 | 1/20 | 0.56 |
| ▸ | HTR2C | P28335 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29804225 | 1.00 | ACE (0.62) | ACESCN9ACTSLCTSSCTSK | |
| SCHEMBL4108869 | 1.00 | ACE (0.62) | ACESCN9ACTSLCTSSCTSK | |
| SCHEMBL21292790 | 1.00 | ACE (0.62) | ACESCN9ACTSLCTSSCTSK | |
| SCHEMBL22091571 | 0.91 | SCN9A (0.69) | ACESCN9ACTSLCTSSCTSK | |
| SCHEMBL22091572 | 0.91 | SCN9A (0.69) | ACESCN9ACTSLCTSSCTSK | |
| SCHEMBL21310053 | 0.90 | TACR1 (0.62) | ACESCN9ACTSLCTSSCTSK | |
| SCHEMBL5123222 | 0.90 | TACR1 (0.62) | ACESCN9ACTSLCTSSCTSK | |
| SCHEMBL5123229 | 0.90 | TACR1 (0.62) | ACESCN9ACTSLCTSSCTSK | |
| SCHEMBL8208133 | 0.89 | MAPT (0.63) | ACESCN9ACTSLCTSSCTSK | |
| SCHEMBL25206905 | 0.89 | BLM (0.60) | TACR1MAPTBLMNPSR1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113087699-A | Peptide-like compound and preparation method and application thereof | 盐城工业职业技术学院 | 2021-07-09 | — | — | CN | claimed |
| US-12570606-B2 | Myeloperoxidase imaging agents | THE GENERAL HOSPITAL CORPORATION (US) | 2026-03-10 | — | — | US | disclosed |
| US-20260015313-A1 | AMINO ACID ACTIVE ESTER AND SALT THEREOF | PEPTIDREAM INC (JP) | 2026-01-15 | — | — | US | disclosed |
| EP-4534524-A1 | AMINO ACID ACTIVE ESTER AND SALT THEREOF | PeptiDream Inc. (JP) | 2025-04-09 | — | — | EP | disclosed |
| EP-3541431-B1 | MYELOPEROXIDASE IMAGING AGENTS | MASSACHUSETTS GEN HOSPITAL (US) | 2024-04-17 | — | — | EP | disclosed |
| WO-2023092133-A1 | STEREOSELECTIVE COVALENT LIGANDS FOR ONCOGENIC AND IMMUNOLOGICAL PROTEINS | THE SCRIPPS RESEARCH INSTITUTE (US) | 2023-05-25 | — | — | WO | disclosed |
| US-20230124429-A1 | Highly Efficient Myeloperoxidase Activatable Imaging Agents | THE GENERAL HOSPITAL CORPORATION | 2023-04-20 | — | — | US | disclosed |
| US-20230124429-A1 | Highly Efficient Myeloperoxidase Activatable Imaging Agents | THE GENERAL HOSPITAL CORPORATION | 2023-04-20 | — | — | US | disclosed |
| CN-110177581-B | Myeloperoxidase imaging agents | 通用医疗公司 | 2023-01-03 | — | — | CN | disclosed |
| US-20220340524-A1 | Myeloperoxidase Imaging Agents | THE GENERAL HOSPITAL CORPORATION | 2022-10-27 | — | — | US | disclosed |
| CN-1040432-C | Spiro piperdines and homologs promote release of growth hormone | MERCK & CO INC (US) | 1998-10-28 | — | — | CN | disclosed |
| US-5578593-A | RELEASING GROWTH HORMONES FOR ANIMALS | MERCK & CO., INC. (US) | 1996-11-26 | — | — | US | disclosed |
| EP-0662481-A1 | Spiro piperidines and homologs promote release of growth hormone | MERCK & CO. INC. (US) | 1995-07-12 | — | — | EP | disclosed |
| CN-1092767-A | Promote spiroperidol and homologue that tethelin discharges | MERCK & CO INC (US) | 1994-09-28 | — | — | CN | disclosed |
| US-5346898-A | FOR TREATING FUNGAL INFECTIONS IN MAMMALS | SCHERING CORPORATION (US) | 1994-09-13 | — | — | US | disclosed |
| WO-1994019367-A1 | SPIRO PIPERIDINES AND HOMOLOGS PROMOTE RELEASE OF GROWTH HORMONE | MERCK & CO., INC. (US) | 1994-09-01 | — | — | WO | disclosed |
| EP-0442878-A4 | DERIVATIVES OF TRYPTOPHAN AS CCK ANTAGONISTS | — | 1991-10-23 | — | — | EP | disclosed |
| EP-0442878-A1 | DERIVATIVES OF TRYPTOPHAN AS CCK ANTAGONISTS | ABBOTT LABORATORIES (US) | 1991-08-28 | — | — | EP | disclosed |
| WO-1989010355-A1 | DERIVATIVES OF TRYPTOPHAN AS CCK ANTAGONISTS | ABBOTT LABORATORIES (US) | 1989-11-02 | — | — | WO | disclosed |
| EP-0336356-A2 | Derivatives of tryptophan as CCK antagonists | ABBOTT LABORATORIES (US) | 1989-10-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260015313-A1 | AMINO ACID ACTIVE ESTER AND SALT THEREOF | NSUN3, BCAT1, SLC43A1 | ACE 1944/4885SCN9A 914/4885CTSL 1563/4885 |
| US-20230124429-A1 | Highly Efficient Myeloperoxidase Activatable Imaging Agents | MPO, CAT, EPX | ACE 369/4885SCN9A 4143/4885CTSL 225/4885 |
| US-20220340524-A1 | Myeloperoxidase Imaging Agents | MPO, CAT, EPX | ACE 149/4885SCN9A 4080/4885CTSL 226/4885 |
| US-12570606-B2 | Myeloperoxidase imaging agents | MPO, CBR1, NOX1 | ACE 726/4885SCN9A 1379/4885CTSL 200/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.